ChemicalBook > Product Catalog >API >Antineoplastic agents >Natural sources of antineoplastic >Homoharringtonine

Homoharringtonine

Homoharringtonine Structure
CAS No.
26833-87-4
Chemical Name:
Homoharringtonine
Synonyms
HHT;HHT2;ORW2;SKR3;ACVRL1;ACVRLK1;CGX 635;Myelostat;Ceflatonin;NSC 141633
CBNumber:
CB2278852
Molecular Formula:
C29H39NO9
Molecular Weight:
545.63
MOL File:
26833-87-4.mol
MSDS File:
SDS
Modify Date:
2024/1/5 22:10:32

Homoharringtonine Properties

Melting point 144-146 C
Boiling point 619.03°C (rough estimate)
Density 1.2395 (rough estimate)
refractive index 1.6290 (estimate)
storage temp. 2-8°C
solubility DMSO: soluble20mg/mL, clear
pka 11.60±0.29(Predicted)
form powder
color white to beige
optical activity [α]/D -120 to -140°, c = 1 in chloroform-d
InChIKey DJIVDDPFKDEQIR-XSEHADPMSA-N

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS06
Signal word  Danger
Hazard statements  H300+H310+H330
Precautionary statements  P262-P280-P301+P310+P330-P302+P352+P310-P304+P340+P310
Hazard Codes  T+,Xi
Risk Statements  26/27/28-36/37/38-28
Safety Statements  36/37/39-45-27-26-36/37-28
RIDADR  UN 1544 6.1/PG 2
WGK Germany  3
RTECS  FK0260000
HazardClass  6.1(a)
PackingGroup  II
NFPA 704
0
4 0

Homoharringtonine price More Price(3)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) SML1091 Homoharringtonine ≥98% (HPLC) 26833-87-4 10MG ₹12383.8 2022-06-14 Buy
Sigma-Aldrich(India) SML1091 Homoharringtonine ≥98% (HPLC) 26833-87-4 50MG ₹49935.73 2022-06-14 Buy
Sigma-Aldrich(India) SAB1412002 ANTI-ACVRL1 antibody produced in mouse clone 1E7, purified immunoglobulin, buffered aqueous solution 26833-87-4 100μG ₹52347.6 2022-06-14 Buy
Product number Packaging Price Buy
SML1091 10MG ₹12383.8 Buy
SML1091 50MG ₹49935.73 Buy
SAB1412002 100μG ₹52347.6 Buy

Homoharringtonine Chemical Properties,Uses,Production

Description

Omacetaxine mepesuccinate (also known as homoharringtonine) was approved by the US FDA in October 2012 for the treatment of patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance or intolerance to at least two tyrosine kinase inhibitors (TKIs). Omacetaxine is a protein synthesis inhibitor that was studied in the 1970s for the treatment of acute myeloid leukemia (AML) and in the 1990s for CML. Emergence of resistance to first- and second-generation TKIs has lead to renewed interest in omacetaxine due to its differentiated mode of action. Omacetaxine acts on the initial step of protein translation andresults in the rapid loss of a number of short-lived proteins that regulate proliferation and cell survival. Omacetaxine induces apoptosis and shows in vitro activity in anumberof leukemia cell lines andinmurine leukemiamodels. Omacetaxineis a naturally occurring alkaloid isolated from Cephalotaxus coniferous shrubs that are indigenous to Asia. Extracts of the bark have been used by practitioners of traditional Chinese medicine for the treatment of cancer. Although omacetaxine could be isolated directly from bark and roots, a more efficient approach is semi-synthesis by esterification of the abundant biosynthetic precursor cephalotaxine, which can be extracted from leaves rather than nonrenewable sources. Esterification is carried out with an activated ester in which the diol side-chain is protected as a tetrahydropyran; after ester formation, the diol is released in two steps under mild conditions.

Chemical Properties

Off-white Cryst

Physical properties

Appearance: an almost white or pale yellow crystalline powder or an amorphous friable solid. It has the hygroscopic nature. It darkens on exposure to light. Solubility: easily soluble in chloroform, ethanol and methanol, and slightly soluble in ether and water. Melting point: 143–147?°C.

History

In China, especially in Fujian, etc., doctors have treated tumor with Cephalotaxus harringtonia long ago. In the early 1970s, American scientists Powell et?al. isolated and identified the alkaloids of the Cephalotaxus plant and studied its antitumor activity. One type of the alkaloids (Cephalotaxine ester, including harringtonine, homoharringtonine, isoharringtonine, deoxyharringtonine, and pseudodeoxyharringtonine) was found to have the effect of inhibiting the proliferation of mouse leukemia cells . Chinese scientists also isolated a large number of harringtonine and homoharringtonine and used them to treat leukemia. Then, the United States and other developed countries’ scientists carried out the Phase I and II clinical research and toxicology research of homoharringtonine.

Uses

Homoharringtonine (HHT) combined with some botanical drugs could induce cancer cells to resemble normal cells. HHT was prepared by a semi-synthetic method from Cephalotaxine, a major alkaloid of Cepahlotaxus species through the formation of a-ketoes

Definition

ChEBI: A cephalotaxine-derived alkaloid ester obtained from Cephalotaxus harringtonia; used for the treatment of chronic or accelerated phase chronic myeloid leukaemia.

Indications

This product is recorded in the Pharmacopoeia of the People’s Republic of China (2015).
Its main dosage form is homoharringtonine injection, which is mainly used for the treatment of chronic myelocytic leukemia and acute myeloid leukemia.

Biological Activity

Inhibitor of protein synthesis. Blocks elongation phase of translation by binding to the 60-S ribosome subunit. Antileukemic.

Pharmacology

Induce apoptosis: Homoharringtonine was found to activate HL-60 cell apoptosis through caspase-3 mediated Bcl-2-Bax, -MAPK pathway .
3. Induce cell differentiation: Homoharringtonine could induce HL-60 cell differentiation by downregulating the expression of CD44 gene, thereby increasing p27 and p21 expression and inhibition of cyclin E activity.
Structure-Activity Relationship (SAR) The methyl acetate group of 2′ position in the C-3 acyl side chain is an active essential group. R group plays a role in regulating the polarity of the molecule, and the size of the R group can affect the molecular activity. The olefinic carbon instead of the 2′ position chiral carbon is still active .

Clinical Use

Synribo® (Omacetaxine mepesuccinate) was approved by the FDA for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) exhibiting resistance or intolerance to tyrosine kinase inhibitors (TKI’s). Omacetaxine mepesuccinate inhibits protein synthesis and prevents aminoacyl-tRNA binding during the elongation phase and targets myeloma-promoting molecules Mcl-1, XIAP, and β-catenin, which are particularly important in the survival of myeloma cells. Omacetaxine mepesuccinate is also known as homoharringtonine, an alkaloid originally discovered and structurally identified from Cephalotaxus harringtonia, which occurs naturally in Japan and eastern Asia.

Anticancer Research

This compound is isolated from Cephalotaxus harringtonia. A racemic mixture ofharringtonine and homoharringtonine is used for acute and chronic myelogenousleukemia (Shoeb 2006).

Homoharringtonine Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 337)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Shanghai Daken Advanced Materials Co.,Ltd +86-371-66670886 China 16914 58 Inquiry
Henan Tianfu Chemical Co.,Ltd. +86-0371-55170693 +86-19937530512 China 21668 55 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29894 58 Inquiry
Chengdu Biopurify Phytochemicals Ltd. +8618080483897 China 3777 58 Inquiry
Shaanxi Pioneer Biotech Co., Ltd . +8613259417953 China 3000 58 Inquiry
Chongqing Chemdad Co., Ltd +86-023-6139-8061 +86-86-13650506873 China 39916 58 Inquiry
CONIER CHEM AND PHARMA LIMITED +8618523575427 China 49391 58 Inquiry
Hubei Ipure Biology Co., Ltd +8613367258412 China 10326 58 Inquiry

Homoharringtonine Spectrum

HOMOHARRINGTONIN HOMOHARRINGTONINE HHT cephalotaxine 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate CEPHALOTAXINE, 4-METHYL-2-HYDROXY-2-[4-HYDROXY-4-METHYLPENTYL] BUTANEDIOATE ESTER CEPHALOTAXINE 4-METHYL (2R)-2-HYDROXY-2-(4-HYDROXY-4-METHYLPENTYL)BUTANEDIOATE 4-methyl-cephalotaxin2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate(e cephalotaxine,4-methyl(2r)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioa Homoharringtonine CP Omacetaxine ACVRL1 ACVRLK1 ANTI-ACVRL1 antibody produced in mouse ALK1 (144-end), active, GST tagged human Anti-ACVRL1 (C-terminal) antibody produced in goat HHT2 ORW2 SKR3 Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester) HOMOHARRINGTONINE(P) HOMOHARRINGTONINUM 4-methylpentyl)butanedioate(ester), [3(R)]- Cephalotaxine, 4-methyl2-hydroxy-2-(4-hydroxy- Ceflatonin CGX 635 Myelostat NSC 141633 Omacetaxine Mepesuccinate (2'R,3S,4S,5R)-(-)-Homoharringtonine Cephalotaxine (R)-2-(methoxycarbonylmethyl)-2,6-dihydroxy-6-methylheptanoate (12S)-12-Hydroxy-5,8,10-heptadecanetricarboxylic acid (2'R,3S,4S,5R)-(-)-hoMoharringtonine, (-)-hoMoharringtonine, hoMoharringtonine, hoMoharrigtonine, harringtonine, HHT, HoMoharringtonine OMAPRO OMACETAXINE MEPESUCCINATE HMoharringtonine OMacetaxine (HoMoharringtonine) HoMoharringtonine (8CI) (2R)-2-hydroxy-2-(4-hydroxy-4-Methylpentyl)butanedioate Cephalotaxine, 3-[4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate] Recombinant Human ALK-1/ACVRL1 Protein, His Tag Recombinant Mouse Acvrl1/ALK-1 Protein, His Tag Human ACVRL1 Protein, Fc Tag Human ACVRL1 Protein, His Tag Rat ACVRL1 Protein, Fc & His Tag Homoharringtonine USP/EP/BP Homoharringtonine (HHT) TIANFU-CHEM Homoharringtonine Omacetaxine Mepesuccinate (Homoharringtonine) Omacetaxine 26833-87-4 Homoharringtonine Omacetaxine Homoharringtonine 26833-87-4 OMACETAXINE MEPESUCCINATE; HHT Homoharringtonine, 98%, from Taxus chinensis (Pilg.) Rehder 1-((11bS,12S,14aR)-13-Methoxy-2,3,5,6,11b,12-hexahydro-1H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-12-yl) 4-methyl (R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)succinate Cytisine Impurity 8 1-((11bS,12S,14aR)-13-Methoxy-2,3,5,6,11b,12-hexahydro-1H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-12-yl) 4-methyl (R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)succinate 26833-87-4 C29H39NO9 C28H39NO9 Apoptosis and Cell Cycle